Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 3 7Phase 1/2 3Phase 2/3 2Phase 1 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Leukemia, Myeloid, Acute 30Leukemia 10Congenital Abnormalities 10Leukemia, Monocytic, Acute 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Myelomonocytic, Acute 7Leukemia, Megakaryoblastic, Acute 7Leukemia, Erythroblastic, Acute 7Recurrence 5Myelodysplastic Syndromes 5Prostatic Neoplasms 2Neoplasms 2Leukemia, Myeloid 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Sarcoma, Myeloid 1Ovarian Neoplasms 1Neoplasm Metastasis 1Lymphoma, T-Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Carcinoma, Ovarian Epithelial 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Docetaxel 43enzalutamide 31Prednisone 25Abiraterone Acetate 24Magnetic Resonance Spectroscopy 18abiraterone 15pembrolizumab 14bicalutamide 14Radiotherapy 14Cyclophosphamide 13darolutamide 12Leuprolide 12Goserelin 12apalutamide 10Ipilimumab 10olaparib 9Specimen Handling 9Radiosurgery 9Radiation 9Injections 9Biopsy 9Pluvicto 8Paclitaxel 8Radiotherapy, Intensity-Modulated 7Carboplatin 7sargramostim 6fludarabine 6cabazitaxel 6Sirolimus 6Nivolumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Prostatic Neoplasms × Mitoxantrone × Clear all
NCT00059631 2018-11-15

Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone

M.D. Anderson Cancer Center

Phase 1 Completed
42 enrolled
Genitourinary

Prostatic Neoplasms

NCT00003633 2013-12-19

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
12 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡